<DOC>
	<DOCNO>NCT00442338</DOCNO>
	<brief_summary>The study estimate efficacy safety MK0476 aminophylline intravenous administration adult participant acute asthma .</brief_summary>
	<brief_title>Study MK-0476 Adult Patients With Acute Asthma ( 0476-334 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Adult participant acute asthma attack Participant know suspect , acute chronic cause pulmonary symptom asthma ( e.g. , COPD , chronic heart failure , etc. ) . Participant smoking habit ( 15 cigarette per day ) within month prior screen period , and/or smoke history ( 20 cigarette per day ) 15 year . Participant disease cardiovascular , hepatic , renal , hematologic system , severe disease .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>